LICENSING PRESENTATION September 2013

Slides:



Advertisements
Similar presentations
PIPELINE INFORMATION. Our mission is simple: make pharmaceutical information technology an asset for your business not a problem. We gather, analyze and.
Advertisements

Global E Lab Starting to Develop your Project Analysis.
Ranbaxy Laboratories Limited Differential Pricing & Financing of Essential Drugs Experience with Generic drugs Cecile H Miles Head of Western Europe Division.
M4U-Concept Market For You in Europe. M4U-Concept OUR TERRITORY IS EUROPE OUR EXPERTS HAVE BUSINESS CONNECTIONS TO THE FOLLOWING BUSINESS SECTORS: BIO.
PRESENTATION VISUAL-STRAT BUSINESS GAME. Entering the Global Market A unique product manufactured in Europe... The Motorcycle!!
Henkel’s Stage-Gate Process (Portugal Division)
What Is the Strategic Perspective?
MedTech Talent Briefing October, 2 nd, 2012 Mary F. Moriarty AvaMed/MassMEDIC.
Maura Kinahan, PhD MPSI “Medicines Shortages - Industry Perspective” 2013 INTERNATIONAL SUMMIT ON MEDICINES SHORTAGE Toronto 20 th -21 st June 2013.
Hale & Tempest The Global Pharmaceutical Industry (MNC & Generic) in Transition Dr. Brian W Tempest The Global Generic Summit – Barcelona,
Tattletale Toy Company ®
Introduction Opportunity Market potential of recombinant drugs Problem Lack of manufacturing capacity Solution PharmOut: Contract BioManufacturing.
DAVID HARDING CPhI 2008 SHANGHAI JUNE 24–26, 2008 Product Selection for API Manufacturers and Generic Pharmaceutical Companies: A Tool for Success.
Jan 2009 INTRODUCTION TO JUBILANT FULLY INTEGRATED SOLUTIONS IN GENERICS.
Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.
Are you looking for an opportunity to join a company that has a long history and an exciting future? A place where you can grow within an international.
Cargo Essence The Gsa of the south to provide an extensive regional GSA solution.
Saks Gloweli Consulting Management Consulting and Market Entry in China.
Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.
Growth and Success through Partnering & Outsourcing.
Copyright 2015 © HSI, LLC. All rights reserved. (949)
Business in a Changing World
Outsourcing Next Level International Proprietary & Confidential Outsourcing: Reaping the Benefits, Managing the Challenges Frances Grigsby April 15, 2005.
Presented by Gary Kibblewhite Chairman: International Distribution of Electronics Association, Milan Chairman: Association of Franchised Distributors of.
Veiovis LifeSciences Pvt Ltd
Best Strategies for a Small Company Dealing with CMOs: What to do when Money is NOT a Motivator Steve Pondell 29 Nov, 2006.
Going Global in LA Presented By Kevin Nikkhoo Managing Partner Sino Century, US.
Drug Delivery and Generic Medicine The Challenge ahead; Choose where to play. MENA as an Industry Model Mohammad Refaat Khattab Cairo University; Egypt.
VED S.A.. VED Your trusted partner for Investment Management, Mergers & Acquisitions and Real Estate Investments VED S.A. 1.
Gedeon Richter Ltd. Founded: 1901 Privatised: International locations: 31 Leading position in the region: CIS, EE, Hungary Niche player in the EU.
Global Hot Swap Controllers Industry 2015 Deep Market Research Report Toll Free: +1 (800) Direct:+1 (503)
SME Instrument. Eligibility Criteria At least one SME established in EU member state or associated country Projects at a TRL level.
Douglas Pharmaceuticals Ltd
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
Global Vacuum Insulation Panel (VIP) Industry 2015 Deep Market Research Report Toll Free: +1 (800) Direct:+1 (503)
Outsourcing in UNILEVER
1 Gary Williams – Director Jeni Clark – Associate Director New Product Development May 16,2012.
INTERNATIONAL MARKETING MANAGEMENT SESSION 13: GLOBAL PORTFOLIO STRATEGY 1.
Global Spirometer Industry 2015 Deep Market Research Report Toll Free: +1 (800) Direct:+1 (503)
© Enterprise Europe Network South West 2009 The Eurostars Programme Kenny Legg R&D Funding for the Environmental Sector – 29 June 2010 European Commission.
Global Graphics Tablet Industry 2015 Deep Market Research Report TELEPHONE:
Commercialization Plan Product Development Business model Financial plan BUSINESS PLAN Development strategy Budgets IDEA Invention Preface Fig 1.
GAIN TOGETHER «One stop shop» Reliable way to CIS market 2015 Multibusiness pharmaceutical company SIA «Pharma World» group.
Cooperative Strategy Cooperative Strategy
Bekaert in brief September 2015 Bekaert in brief - Founded in 1880 by Leo Leander Bekaert - Customers in 120 countries and in the most diverse industry.
We support you in finding your feet in your new country by introducing you to the network of local Europportunity interns to help you find an apartment.
INTERNATIONAL MARKETING MANAGEMENT SESSION 13: GLOBAL PORTFOLIO STRATEGY 1.
128/02/2011 Confidential Who is Alcimed ? ALCIMED is a European consulting company specialized in Life Sciences/Healthcare and Chemicals, founded in 1993.
Global and China Neutral protease Industry Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast,
Global Beta Cyfluthrin Industry Size, Trends, Segmentation Research 2015 Published: Sep 2015 Single User License: US$ 2800 Corporate User License: US$
2015 Market Research Report on Global Water and Wastewater Treatment Chemicals Industry Published: Jan 2015 Single User License: US$ 2600 Corporate User.
2015 © COPYRIGHT BY YAZAKI EUROPE LTD. ANY REPRODUCTION OR DISCLOSURE IS PROHIBITED WITHOUT PRIOR WRITTEN CONSENT OF YAZAKI 1 INSPIRING VISION BUILT ON.
Rigid Endoscopes : Medical Device Industry Research And Analysis
Endoscopy Visualization Systems - Medical Devices Pipeline Assessment
Global Cellulosics Sales Market Analysis: Development Trends
Global Cork Stoppers Sales Market Report Report Highlights Analysis is provided for the international markets including development trends, competitive.
Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2016
Nucleus Replacement Medical Devices Market Size, Share & Forecast
Global Perchloroethylene Market Research Report 2017.
Global PU Foam Stabilizer Market Research Report 2017.
Global Internet of Things (IoT) Security Market By Manufacturers, Countries, Type And Application, Forecast To 2022 Global Internet of Things (IoT) Security.
OVER 20 YEARS OF EXPERIENCE IN CHEMICAL AND PHARMA INDUSTRY
14 Summary Management of Operations
Global Top Countries Dental Laboratory Workstations Market Report
Pragmatic Marketing Framework™
Global Top Countries Stairlift Market Report
We are A Mumbai based, export oriented pharmaceutical company A one-stop-shop to all your import requirements. Our Vision To make the best quality healthcare.
COMPANY NAME/ PRODUCT NAME
Proactive One2One Healthcare Forum July 11th 2019
I4.0 in Action The importance of people and culture in the Industry 4.0 transformation journey Industry 4.0 Industry 3.0 Industry 2.0 Industry 1.0 Cyber.
Presentation transcript:

LICENSING PRESENTATION September 2013 Tristram Lake Head of Licensing and Sales Neogen N.V.

CONTENTS The aim of this presentation is to communicate to you... Our mission Our vision Who we are What we do How we do it

Who are we? Developments International Alter Pharma N.V. Neogen Dev. Interntational SP NSP GSP Steac Developments International

our Basic idea We cover niche, overlooked and local markets with focus on older molecules, along with alternative forms and strengths when possible Neogen Generic Companies wishing to extend their Portfolio No skills or willingness to undertake developments Inlicensing of products

Roadmap 2 – 4 years Core competences Market intel Product selection Finished dose development Dossier compilation Submission & registration Supply & support API development Sales & marketing Core competences Market intel Qualification & management of 3rd party CMO’s Patent search Commercial scale production Formulation Stability testing Risk assessment Regulatory strategy Lab scale batches

Dosage FORMs Injectables: In-house development. EU CMOs Oral forms: 3rd party development or dossier update manufacturing outsourced in Europe and Asia BE performed if necessary Other forms: creams, sprays Developed and manufactured in EU based CMOs Supported by clinical study if necessary

SELECTION PRODUCT Opportunity driven Focus on niche products (turnover < EUR 20 million or available only in limited number of countries). 25 projects completed or in final development stages Approx. 60 other projects in pipeline Several products already launched

WIN Business Model License and long term supply agreement Dossier fee Supply price model adapted to product and territory Registration support Supply chain management Ex-works

COMPANY FIGURES Team of circa 30 people located in Belgium, Denmark, France, Hungary, Ireland, Netherlands 2012 turnover EUR 14 mio. 5 products launched in 30 countries License and Supply deals signed for ANZAC, Canada, China, Europe, LATAM, MENA, RSA, Russia/CIS, SAE, US > 120 License and Supply deals signed > 70 clients Distribution deals done in non-regluated markets

OUR STRENGTHS Multicultural team, allowing local focus with global perspective Strong expertise in: product selection dossier development licensing-out supply of product to the pharma industry Dynamic, fast and pragmatic decision process

Advantages of partnering with Us Full Regulatory Support: before, during and after granting MA Supply Chain Management Continuos Competitive Sourcing: API + Manufacturer Sourcing Strategy: 2 APIs sources + 2 Manufacturers (Asia, EU) Flexibility and speed Outsourcing advantages Fast moving, dynamic company with global experience

CONTACT Tristram Lake Head of Licensing NEOGEN N.V. Square Marie Curie 50 – 1070 Anderlecht – Belgium tristram.lake@neogen.be - licensing@neogen.be